Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -269,108 | -203,989 | -134,603 | -90,935 | -143,551 |
| Depreciation Amortization | 2,245 | 1,673 | 1,110 | 553 | 2,191 |
| Accounts receivable | -10,546 | -9,322 | -9,466 | -4,942 | -12,388 |
| Accounts payable and accrued liabilities | -34,099 | -30,833 | -22,182 | -21,583 | 23,106 |
| Other Working Capital | -52,513 | -46,929 | -30,641 | -9,362 | -4,262 |
| Other Operating Activity | 100,212 | 83,297 | 58,848 | 37,201 | 49,727 |
| Operating Cash Flow | $-263,809 | $-206,103 | $-136,934 | $-89,068 | $-85,177 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -869 |
| Purchase Of Investment | -50,484 | N/A | 0 | N/A | -4,420 |
| Sale Of Investment | N/A | N/A | 0 | N/A | 39,145 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -12,500 |
| Investing Cash Flow | $-50,484 | $N/A | $N/A | $N/A | $21,356 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 280,000 |
| Common Stock Issued | 222,450 | 7,599 | 2,836 | 2,668 | 6,634 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -55,000 |
| Other Financing Activity | 45,773 | 47,214 | 48,322 | -623 | -29,909 |
| Financing Cash Flow | $268,223 | $54,813 | $51,158 | $2,045 | $201,725 |
| Beginning Cash Position | 304,962 | 304,962 | 304,962 | 304,962 | 167,058 |
| End Cash Position | 258,892 | 153,672 | 219,186 | 217,939 | 304,962 |
| Net Cash Flow | $-46,070 | $-151,290 | $-85,776 | $-87,023 | $137,904 |
| Free Cash Flow | |||||
| Operating Cash Flow | -263,809 | -206,103 | -136,934 | -89,068 | -85,177 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -869 |
| Free Cash Flow | -263,809 | -206,103 | -136,934 | -89,068 | -86,046 |